Permanent interstitial implantation using palladium-103: the New York Medical College preliminary experience.

@article{Porrazzo1992PermanentII,
  title={Permanent interstitial implantation using palladium-103: the New York Medical College preliminary experience.},
  author={Michael Porrazzo and Basil S. Hilaris and Chitti R. Moorthy and A. E. Tchelebi and Constance A Mastoras and L L Shih and Laura P. Stabile and Nikolaos Salvaras},
  journal={International journal of radiation oncology, biology, physics},
  year={1992},
  volume={23 5},
  pages={1033-6}
}
Palladium-103 is a low energy photon emitter available for permanent interstitial implantation. Pd-103 has energy and safety characteristics similar to Iodine-125, but its initial peripheral dose rate is approximately three times greater. This may provide improved control of rapidly proliferating tumors. At the Westchester Campus of New York Medical College, 15 patients with residual or recurrent unresectable lesions were implanted with Pd-103. There were five males and 10 females with an age… CONTINUE READING

Similar Papers

Loading similar papers…